Therapeutic efficacy and safety of photodynamic therapy in patients with central serous chorioretinopathy

Therapeutic efficacy and safety of photodynamic therapy in patients with central serous chorioretinopathy - Clinical trial of PDT in patients with CSC

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025069

Enrollment

Registered

2017-01-31

Start date

2017-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central serous chorioretinopathy

Interventions

now writing

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: now writing

Exclusion criteria

Exclusion criteria: A patient with anaphylactic shock against verteporfin

Design outcomes

Primary

Measure	Time frame
Visual acuity	—

Secondary

Measure	Time frame
Central retinal thickness, fundus autofluorescence	—

Countries

Japan

Contacts

Public ContactHisashi Iwami

Hyogo college of Medicine Ophthalmology

hi-iwami@hyo-med.ac.jp0798-45-6462

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026